Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Schouw & Co. share buy-back programme, week 19 2024
-
Nano® Hearing Aids Names Ryan Zackon as Chief Executive Officer
-
Everything Blockchain Inc. Partners with BlackLake Security
-
Everything Blockchain Inc. Partners with BlackLake Security
-
LPL Financial Welcomes Noble Traditions Wealth
-
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Coveo Announces Date of Fiscal Fourth Quarter 2024 Conference Call
-
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
-
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Squarespace, Inc. and Encourages Investors to Contact the Firm
-
Grand Prairie Student Wins NFTE's South Youth Entrepreneurship Challenge
-
Roblon announces changes to the Executive Management
-
DEADLINE TOMORROW: Berger Montague Advises Innoviz Technologies Ltd. (NASDAQ: INVZ) Investors to Inquire About a Securities Fraud Class Action by May 14, 2024
-
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2% Year-on-Year Increase
-
Safety Shot Partners with Gopuff
-
Alliance Trust PLC - Net Asset Value
-
Stanley Martin Holdings Acquires Prestige Corporate Development and Prestige Site Works
-
Dorel Industries Inc. Announces Virtual Annual Meeting of Shareholders
-
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
-
Live Ventures Reports Fiscal Second Quarter 2024 Financial Results
-
Madison Realty Capital and Unity Capital Originate $100 Million Construction Loan for Mixed-Use Multifamily Development in Long Branch, New Jersey
-
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
-
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
-
TransCode Therapeutics Open Letter to Shareholders
-
Husky Technologies™ Leverages ARHT Hologram Technology to Showcase Sustainable Solutions at the Premier Plastics Tradeshow in Orlando
-
KULR Adds United Parcel Service to its Battery Safety Shipping Platform, Forms Strategic Partnership with Safeware for Online Marketplace
-
SHEIN Unveils Move & Groove Pop-Up at Ottawa's ByWard Market
-
Nevada Exploration Inc. Appoints New President and CEO
-
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Tri
-
Barfresh Enters into Agreement with Largest Regional Sales Broker in the Southeast
-
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
-
TransCode Therapeutics Open Letter to Shareholders
-
NANO Nuclear Energy Announces Closing of $10,250,000 Initial Public Offering
-
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2024 and Operational Update
-
FundCanna Chosen by Dama as a Key Partner for Cannabis Lending
-
Haveli Investments Completes Acquisition of ZeroFox
-
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
-
Raymond James Establishes New Private Credit Business
-
Delmar Solidifies Presence in the Netherlands with Acquisition of Intervracht Nederland BV
-
Abliva to Host Virtual KOL Event on KL1333 in Primary Mitochondrial Disease on May 21, 2024
-
CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR FIRST QUARTER 2024
-
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
-
LM Funding America, Inc. Schedules First Quarter 2024 Financial Results and Business Update Conference Call
-
Stream Companies selected as Genesis Certified Digital Advertising Vendor
-
Development of 911 variant with hybrid powertrain complete
-
Warner Music Group Corp. Announces Quarterly Cash Dividend
-
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
-
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
-
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
-
Ocean Power Technologies Announces Renewable Energy Production Milestone
-
Royalty Pharma to Present at Upcoming Investor Conferences
